[1]Bachettini NP, Bielemann RM, Barbosa-Silva TG, et al. Sarcopenia as a mortality predictor in community-dwelling older adults: a comparison of the diagnostic criteria of the European Working Group on Sarcopenia in Older People [J]. Eur J Clin Nutr, 2020, 74: 573-580. [2]Conte M, Santoro A, Collura S, et al. Circulatingperilipin 2 levels are associated with fat mass, inflammatory and metabolic markers and are higher in women than men [J]. Aging (Albany NY),2021, 13:7931-7942. [3]Xu L, Lu Y, Li N, et al. Cross-sectional associations of adipokines and abdominal fat distribution with aging in men [J]. Aging Male, 2020, 23:1576-1582. [4]Perry RJ, Lyu K, Rabin-Court A, et al. Leptin mediates postprandial increases in body temperature through hypothalamus-adrenal medulla-adipose tissue crosstalk [J]. J Clin Invest, 2020, 130:2001-2016. [5]Tazawa R, Uchida K, Fujimaki H, et al. Elevated leptin levels induce inflammation through IL-6 in skeletal muscle of aged female rats [J]. BMC Musculoskelet Disord, 2019, 20:199.doi:10.1186/s12891-019-2581-5. [6]Manoy P, Anomasiri W, Yuktanandana P, et al. Elevated serum leptin levels are associated with low vitamin D, sarcopenic obesity, poor muscle strength, and physical performance in knee osteoarthritis [J]. Biomarkers, 2017, 22:723-730. [7]Balasubramanian P, Schaar AE, Gustafson GE, et al. Adiponectin receptor agonist AdipoRon improves skeletal muscle function in aged mice [J]. Elife, 2022, 11:71282.doi:10.7554/eLife.71282. [8]Santoro A, Guidarelli G, Ostan R, et al. Gender-specific association of body composition with inflammatory and adipose-related markers in healthy elderly Europeans from the NU-AGE study [J]. Eur Radiol, 2019, 29:4968-4979. [9]Biercewicz M, Slusarz R, Kedziora-Kornatowska K, et al. Assessment of leptin-to-adiponectin ratio in prediction of insulin resistance and nutrition status in a geriatric female population [J]. J Physiol Pharmacol, 2020, 71:10.doi: 10.26402/jpp.2020.1.02. [10]Li CW, Yu K, Shyh-Chang N, et al. Circulating factors associated with sarcopenia during ageing and after intensive lifestyle intervention [J]. J Cachexia Sarcopenia Muscle, 2019, 10:586-600. [11]Chen TC, Huang TH, Tseng WC, et al. Changes in plasma C1q, apelin and adropin concentrations in older adults after descending and ascending stair walking intervention [J]. Sci Rep, 2021, 11:17644.doi: 10.1038/s41598-021-96631-x. [12]O'Leary MF, Wallace GR, Davis ET, et al. Obese subcutaneous adipose tissue impairs human myogenesis, particularly in old skeletal muscle, via resistin-mediated activation of NFκB [J]. Sci Rep, 2018, 8:15360.doi: 10.1038/s41598-018-33840-x. [13]VAN Hollebeke RB, Cushman M, Schlueter EF, et al. Allison MA. Abdominal muscle density is inversely related to adiposity inflammatory mediators [J]. Med Sci Sports Exerc, 2018, 50:1495-1501. [14]Shenas NY, Peeri M, Delfan M. The effect of 10 weeks endurance training on protein levels of NF-κB and gene expression of Atrogin-1 and MuRF-1 in cardiac myocytes of female [J]. Med J Tabriz Univ Med Sci, 2021, 43:134-141. [15]Nicholson T, Church C, Tsintzas K, et al. Vaspin promotes insulin sensitivity of elderly muscle and is upregulated in obesity [J].J Endocrinol, 2019, JOE-18-0528.R3. doi:10.1530/JOE-18-0528. [16]Wang J, Zhang K, Zhang S, et al. Vaspin promotes chondrogenic differentiation of BMSCs via Akt activation in osteoarthritis [J]. BMC Musculoskelet Disord, 2022, 23:344.doi:10.1186/s12891-022-05295-9. [17]He H, Lu M, Shi H, et al. Vaspin regulated cartilage cholesterol metabolism through miR155/LXRα and participated in the occurrence of osteoarthritis in rats [J]. Life Sci,2021, 269:119096.doi:10.1186/s12891-022-05295-9. [18]Tarabeih N, Kalinkovich A, Shalata A, et al. Circulating levels of visceral adipose tissue-derived serine protease inhibitor (Vaspin) appear as a marker of musculoskeletal pain disability [J]. Diagnostics (Basel), 2020, 10:797.doi: 10.3390/diagnostics10100797. [19]Rong YD, Bian AL, Hu HY, et al. Study on relationship between elderly sarcopenia and inflammatory cytokine IL-6, anti-inflammatory cytokineIL-10 [J]. BMC Geriatr, 2018, 18:308.doi: 10.1186/s12877-018-1007-9. [20]Li C, Yu K, Shyh-Chang N, et al. Circulating factors associated with sarcopenia during ageing and after intensive lifestyle intervention [J]. J Cachexia Sarcopenia Muscle, 2019, 10: 586-600. [21]Blanco JR, Romero L, Ramalle-Gomara E, et al. Retinol-binding protein 4 (RBP4), a potential biomarker of frailty in HIV-infected people on stable antiretroviral therapy [J]. HIV Med, 2020, 21:358-364. [22]Chang CL, Li YR, Wang ZY, et al. Serum retinol binding protein 4 as a potential biomarker for sarcopenia in older adults [J]. J Gerontol A Biol Sci Med Sci, 2022, glac151. doi:10.1093/gerona/glac151. [23]Tarabeih N, Shalata A, Trofimov S, et al. Growth and differentiation factor 15 is a biomarker for low back pain-associated disability [J]. Cytokine, 2019, 117:8-14. |